Literature DB >> 7668281

Mutation of the PAX6 gene in patients with autosomal dominant keratitis.

F Mirzayans1, W G Pearce, I M MacDonald, M A Walter.   

Abstract

Autosomal dominant keratitis (ADK) is an eye disorder chiefly characterized by corneal opacification and vascularization and by foveal hypoplasia. Aniridia (shown recently to result from mutations in the PAX6 gene) has overlapping clinical findings and a similar pattern of inheritance with ADK. On the basis of these similarities, we used a candidate-gene approach to investigate whether mutations in the PAX6 gene also result in ADK. Significant linkage was found between two polymorphic loci in the PAX6 region and ADK in a family with 15 affected members in four generations (peak LOD score = 4.45; theta = .00 with D11S914), consistent with PAX6 mutations being responsible for ADK. SSCP analysis and direct sequencing revealed a mutation in the PAX6 exon 11 splice-acceptor site. The predicted consequent incorrect splicing results in truncation of the PAX6 proline-serine-threonine activation domain. The SeyNeu mouse results from a mutation in the Pax-6 exon 10 splice-donor site that produces a PAX6 protein truncated from the same point as occurs in our family with ADK. Therefore, the SeyNeu mouse is an excellent animal model of ADK. The finding that mutations in PAX6 underlie ADK, along with a recent report that mutations in PAX6 also underlie Peters anomaly, implicates PAX6 broadly in human anterior segment malformations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668281      PMCID: PMC1801269     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

Review 2.  Pax in development.

Authors:  P Gruss; C Walther
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

3.  Keratoendotheliitis fugax hereditaria. A clinical and specular microscopic study of a family with dominant inflammatory corneal disease.

Authors:  P Ruusuvaara; K Setälä
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-04

4.  A user-friendly Hypercard interface for human linkage analysis.

Authors:  B E Nichols; V C Sheffield; E M Stone
Journal:  Comput Appl Biosci       Date:  1993-12

5.  Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus.

Authors:  W Schmahl; M Knoedlseder; J Favor; D Davidson
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells.

Authors:  A M Carothers; G Urlaub; D Grunberger; L A Chasin
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.

Authors:  T Glaser; L Jepeal; J G Edwards; S R Young; J Favor; R L Maas
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

8.  Quail Pax-6 (Pax-QNR) encodes a transcription factor able to bind and trans-activate its own promoter.

Authors:  S Plaza; C Dozier; S Saule
Journal:  Cell Growth Differ       Date:  1993-12

9.  Paired box mutations in familial and sporadic aniridia predicts truncated aniridia proteins.

Authors:  A Martha; R E Ferrell; H Mintz-Hittner; L A Lyons; G F Saunders
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

10.  Autosomal dominant keratitis: a possible aniridia variant.

Authors:  W G Pearce; B W Mielke; D T Hassard; H W Climenhaga; D B Climenhaga; E J Hodges
Journal:  Can J Ophthalmol       Date:  1995-04       Impact factor: 1.882

View more
  28 in total

1.  PAX6 expression in the developing human eye.

Authors:  S Nishina; S Kohsaka; Y Yamaguchi; H Handa; A Kawakami; H Fujisawa; N Azuma
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

Review 2.  Congenital iris ectropion as an indicator of variant aniridia.

Authors:  C Willcock; J Grigg; M Wilson; P Tam; F Billson; R Jamieson
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

3.  Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-closure glaucoma maps to chromosome 11.

Authors:  M I Othman; S A Sullivan; G L Skuta; D A Cockrell; H M Stringham; C A Downs; A Fornés; A Mick; M Boehnke; D Vollrath; J E Richards
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

4.  Autosomal dominant Axenfeld-Rieger anomaly maps to 6p25.

Authors:  D B Gould; A J Mears; W G Pearce; M A Walter
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Peters' anomaly.

Authors:  T Jordan
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

6.  Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25.

Authors:  A J Mears; F Mirzayans; D B Gould; W G Pearce; M A Walter
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Familial Limbal Stem Cell Deficiency: Clinical, Cytological and Genetic Characterization.

Authors:  Lubica Dudakova; Sek-Shir Cheong; Stanislava Reinstein Merjava; Pavlina Skalicka; Marcela Michalickova; Michalis Palos; Gabriela Mahelkova; Deli Krizova; Martin Hlozanek; Marie Trkova; Jena L Chojnowski; Enkela Hrdlickova; Nikolas Pontikos; Vincent Plagnol; Viera Veselá; Katerina Jirsova; Alison J Hardcastle; Martin Filipec; James D Lauderdale; Petra Liskova
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

8.  Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia.

Authors:  Dominique Brémond-Gignac; Pierre Bitoun; Linda M Reis; Henri Copin; Jeffrey C Murray; Elena V Semina
Journal:  Mol Vis       Date:  2010-08-22       Impact factor: 2.367

Review 9.  SOX genes: architects of development.

Authors:  H M Prior; M A Walter
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

10.  Three novel PAX6 mutations in patients with aniridia.

Authors:  W Zumkeller; U Orth; A Gal
Journal:  Mol Pathol       Date:  2003-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.